At Roivant, we are passionate about discovering and developing new drugs to impact patients' lives. Since its inception in 2014, Roivant has launched over 20 portfolio companies (Vants), overseen 5 successful IPOs, established a $3B partnership with a global pharma, built a pipeline of over 40 assets across various modalities and therapeutic areas, and delivered 8 successful phase 3 readouts. Roivant is currently building new capabilities in drug discovery and expanding its existing development engine to become the world's leading tech-enabled pharmaceutical company.

At Roivant Discovery, we have built a proprietary suite of proteome-wide datasets, assays, and compound collections to systematically prosecute targets via covalency. We are leading the field of covalent drug discovery, expanding the druggable proteome, and unlocking the next generation of high-value small molecule therapeutics across disease areas. This role is an opportunity to be an architect of this paradigm shift and generate transformative benefits for patients.

Our goal is to improve human health by rapidly discovering, developing, and delivering innovative medicines and technologies to all patients. Our success is predicated on attracting and retaining top talent, generating new ideas and promoting an open and collaborative culture.

We embrace diversity across all dimensions and levels of the organization and we strive to ensure every employee is supported in reaching their full potential. We hire motivated people with diverse backgrounds, identities, experiences and skillsets. We are committed to fostering an inclusive culture where all employees feel valued, respected and empowered to create value for patients.

Position Summary:

We are recruiting a Senior Investigator - Computational Proteomics to the Translational Proteomics group. The successful candidate will support the build of our computational (chemo)proteomics platform and drive data processing, analysis, integration, and visualization capabilities. S/he must have a strong desire to develop and apply computational strategies aimed to expand the druggable proteome. The candidate is expected to work closely with database engineers, multi-omics, chemo-informatics, and experimental scientists in our interdisciplinary team and across the entire organization. This is an exceptional opportunity to join a newly founded group that is pushing the boundaries of mass spectrometry-based (chemo)proteomics to accelerate the translation of basic science into clinical solutions.

Job Responsibilities:

  • Build, optimize and automate chemo- and affinity proteomics data processing and analysis workflows.
  • Support the build and design of a proprietary human Disease Reactome database enabled by translational disease models.
  • Support systematic mapping of side-chain post-translational status, functionality, reactivity, and expression levels across disease-relevant biosamples.
  • Analyze data from high-throughput (chemo)proteomics screens in collaboration with Roivant’s multi-omics and translational informatics groups to enable systematic functional insight and shape research hypotheses.
  • Collaborate with interdisciplinary and cross-functional drug discovery teams to expand the druggable proteome. Be exposed to multiple stages of drug discovery and regularly present research findings to the team.
  • Interface with academic collaborators and CROs to implement novel computational deep learning technologies and push the boundaries of proteomic data processing, analysis, and visualization.
  • Publish research in high-profile journals and represent the company at scientific conferences. 

Requirements:

  • PhD. in computational biology/proteomics, bioinformatics, or an associated field (M.Sc. candidates with relevant skills and experience will also be considered). Experience in the drug discovery industry is advantageous.
  • Proven track record of processing, analyzing, visualizing, and integrating quantitative proteomics datasets to generate actionable insights. Experience with structural proteomics is a plus.
  • Strong coding abilities and fluency in at least one programming language (e.g., Python, R). Strong expertise in the analysis of “big data” and data exploration using interactive visualization environments (e.g., Spotfire, R Shiny).
  • Sound understanding of statistical concepts and best practices.
  • Creative and independent thinker with demonstrated ability to solve complex technical and scientific problems.
  • Highly self-motivated, with excellent attention to detail and strong organizational and communication skills.
  • Ability to work independently, yet team-oriented and capable of building strong relationships with peers, customers, and partners/collaborators.

 

Roivant Sciences provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws

Apply for this Job

* Required

  
  


Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Roivant Sciences’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.


Form CC-305

OMB Control Number 1250-0005

Expires 05/31/2023

Voluntary Self-Identification of Disability

Why are you being asked to complete this form?

We are a federal contractor or subcontractor required by law to provide equal employment opportunity to qualified people with disabilities. We are also required to measure our progress toward having at least 7% of our workforce be individuals with disabilities. To do this, we must ask applicants and employees if they have a disability or have ever had a disability. Because a person may become disabled at any time, we ask all of our employees to update their information at least every five years.

Identifying yourself as an individual with a disability is voluntary, and we hope that you will choose to do so. Your answer will be maintained confidentially and not be seen by selecting officials or anyone else involved in making personnel decisions. Completing the form will not negatively impact you in any way, regardless of whether you have self-identified in the past. For more information about this form or the equal employment obligations of federal contractors under Section 503 of the Rehabilitation Act, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

You are considered to have a disability if you have a physical or mental impairment or medical condition that substantially limits a major life activity, or if you have a history or record of such an impairment or medical condition.

Disabilities include, but are not limited to:

  • Autism
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, or HIV/AIDS
  • Blind or low vision
  • Cancer
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or hard of hearing
  • Depression or anxiety
  • Diabetes
  • Epilepsy
  • Gastrointestinal disorders, for example, Crohn's Disease, or irritable bowel syndrome
  • Intellectual disability
  • Missing limbs or partially missing limbs
  • Nervous system condition for example, migraine headaches, Parkinson’s disease, or Multiple sclerosis (MS)
  • Psychiatric condition, for example, bipolar disorder, schizophrenia, PTSD, or major depression

1Section 503 of the Rehabilitation Act of 1973, as amended. For more information about this form or the equal employment obligations of Federal contractors, visit the U.S. Department of Labor's Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.